Metagenomi to Present at the Longwood Healthcare Leaders Spring Webconference

EMERYVILLE, Calif.--(BUSINESS WIRE)--Metagenomi, a genetic medicines company with a versatile portfolio of next-generation gene editing tools, today announced that Simon Harnest, Chief Investment Officer and SVP, Strategy of Metagenomi, will participate in a panel at the Longwood Healthcare Leaders Spring Webconference which will be held virtually on Wednesday, May 4, 2022.

Registration for the event can be found here.

Longwood Healthcare Leaders Spring Webconference

Panel Title: Advancing Platform Technologies
Participant: Simon Harnest, Chief Investment Officer and SVP, Strategy, Metagenomi
Date: Wednesday, May 4, 2022
Time: 1:00 p.m. ET

About Metagenomi
Metagenomi is a gene editing company committed to developing potentially curative therapeutics by leveraging a proprietary toolbox of next-generation gene editing systems to accurately edit DNA where current technologies cannot. Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. We adapt and forge these naturally evolved systems into powerful gene editing systems that are ultra-small, extremely efficient, highly specific and have a decreased risk of immune response. These systems fuel our pipeline of novel medicines and can be leveraged by partners. Our goal is to revolutionize gene editing for the benefit of patients around the world. For more information, please visit https://metagenomi.co/.